TrialBlood2017

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.

Kevin A Hay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.